Surgical Robotics Technology
DePuy Synthes, The Orthopaedics Company of Johnson & Johnson* and part of Johnson & Johnson MedTech**, will showcase new innovation and technological advancements across its comprehensive Spine portfolio, including interactive education opportunities and hands-on demonstrations of the company’s latest innovation – the TriALTIS™ Spine System – at the 31st International Meeting on Advance Spine Techniques (IMAST) 2024, taking place from April 10 to 13, 2024 in San Diego, California.
The TriALTIS™ Spine System is a next generation posterior thoracolumbar pedicle screw system that offers a comprehensive implant portfolio and advanced instrumentation designed for integration with enabling technology. Combined with TriALTIS™ Navigation Enabled Instruments, the TriALTIS™ Spine System aims to address unmet clinical needs across complex spine conditions, including degenerative, tumor, trauma and deformity pathologies.
The TriALTIS™ Spine System was designed around three pillars: technology that enables seamless integration with power and navigation, reliability rooted in the proven legacy of DePuy Synthes Spine implants, and innovation that offers a new development platform and consistent user experience across all indicated pathologies. Both the TriALTIS™ Spine System and TriALTIS™ Navigation Enabled Instruments are now available in the U.S.
“We are thrilled to officially launch the TriALTIS™ Spine System,” said Russell Powers†, Worldwide President, Spine, DePuy Synthes. “Our dedication to improving patient outcomes and optimizing the surgeon experience is evident in every aspect of this system – from its seamless integration with power and navigation, to its precision in implant placement to drive more efficiency in the operating room. The TriALTIS™ Spine System marks a significant stride in the future of surgical excellence, and we’re excited to continue to pioneer innovation that helps to advance the treatment of complex spine conditions for surgeons and their patients.”
*DePuy Synthes represents the products and services of DePuy Synthes, Inc. and its affiliates.
**Comprising the surgery, orthopaedics, vision, and interventional solutions businesses within Johnson & Johnson’s MedTech segment.
†Russell Powers is an employee of Medical Device Business Services, Inc.
Source: Johnson & Johnson
